Thomasin

Quick links to important sections

Thomasin

Method of action: Cardiac Therapy

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Thomasin

Thomasin is a pharmaceutical preparation intended for systemic use, whose single active ingredient is Etilefrine. It is classified as an antihypotensive agent, meaning its primary role is to stabilize and raise abnormally low blood pressure.

Property Description
Active ingredient Etilefrine (typically as Etilefrine Hydrochloride)
Form Tablets (Oral), Solution (Parenteral/Injectable)
Pharmacological class Sympathomimetic Agent, Adrenergic Agonist
Common use Management of low blood pressure (hypotension)
Origin Synthetic, Phenethylamine derivative

What Type of Medicine is Thomasin?

Thomasin belongs to the adrenergic agonist class, which acts by mimicking the effects of the body's natural signaling molecules in the sympathetic nervous system. Its active ingredient, Etilefrine, is categorized as an adrenergic agonist primarily targeting alpha1 and beta1 receptors. This pharmacological action immediately identifies the drug as a vasopressor and cardiotonic agent. The scientific classification confirms that this medicine works by directly stimulating the systems responsible for heart function and vascular tone, a mechanism that is clinically recognized for its utility in restoring circulatory stability.


Composition, Origin, and Available Forms

The core of Thomasin is the synthetic small molecule Etilefrine, which is a phenethylamine derivative chemically related to endogenous compounds. Etilefrine is used as a single-ingredient product, guaranteeing that its effects are solely attributable to its adrenergic activity. The medication is commonly supplied for systemic administration as solid tablets for oral intake and as an injectable solution for parenteral use. The availability of both oral and injectable forms is a differentiating factor, allowing for varied administration depending on the patient's immediate circulatory needs.


What is the General Purpose of Thomasin?

The general purpose of Thomasin is to help relieve symptoms associated with abnormally low blood pressure, or hypotension, including forms like orthostatic hypotension. This is achieved by combining two main physiological actions: it causes blood vessels to tighten, increasing resistance, and it strengthens the heart's pumping force, increasing output. Clinical experience has confirmed that this medicine is particularly suited for individuals who experience dizziness or lightheadedness when moving from a sitting to a standing position, a typical use scenario for this class of agents. The overall goal is to ensure adequate and consistent blood flow to vital organs.

Regulatory References

  1. Hypotension (Low Blood Pressure) - MedlinePlus

What side effects are possible with Thomasin?

Possible side effects and safety information

The safety profile for Thomasin (Etilefrine) is primarily defined by its regulatory classification of adverse reactions and specific limitations on use, which are based on its action as a sympathomimetic agent. Adverse effects are grouped by the physiological system they affect and their expected frequency, as documented in official prescribing information.


Frequency-Classified Adverse Reactions

The most frequently reported adverse reaction is Headache, which is officially classified as Common (reported in at least 1 in 100 people). Adverse reactions classified as Uncommon (reported in at least 1 in 1,000 people) include cardiovascular and neurological effects such as Palpitations, Tachycardia, Arrhythmia, Anxiety, Insomnia, Tremor, Restlessness, Dizziness, and Nausea.

Events that have been documented but for which the frequency cannot be estimated from available data (Not Known) include Hypersensitivity reactions, Angina pectoris (chest pain), and a marked increase in blood pressure.


Key Safety Restrictions and Considerations

The official labeling outlines specific conditions that restrict the use of Thomasin due to the risk of exacerbating pre-existing health issues. The medicine is contraindicated (should not be used) in individuals with several pre-existing cardiovascular conditions, including Hypertension (high blood pressure), Coronary Artery Disease, and certain Arrhythmias. Other contraindications include Hyperthyroidism, Pheochromocytoma, and Closed-Angle Glaucoma.

Specific safety considerations also apply to certain populations. Use of Thomasin is officially contraindicated during the first trimester of pregnancy due to the potential to impair uteroplacental perfusion. It is also contraindicated during lactation (breastfeeding).

Overdose and Emergency Response

Official Overdose Manifestations

The officially documented signs of Thomasin (Etilefrine) overdose, derived from regulatory labeling, focus primarily on its sympathomimetic effects. Manifestations may include pronounced cardiovascular changes such as sustained increased blood pressure (hypertension), palpitations, tachycardia, and potentially cardiac arrhythmias. Non-cardiac symptoms documented are anxiety, headache, mydriasis (pupil dilation), tremor, vomiting linked to increased intracranial pressure, and sometimes cramps.

Severe Outcomes and Emergency Action

Overdose may lead to severe systemic outcomes including possible hyperthermia and rhabdomyolysis. Urgent medical attention must be sought immediately if severe symptoms are present, particularly sustained hypertension or pronounced tachycardia. The regulatory management strategy is primarily symptomatic treatment, as no specific antidote is documented.

Management and Monitoring

Official procedures include the use of gastric lavage if justified, and the administration of activated charcoal. Management of severe hypertension requires the use of specific pharmacological agents, such as Labetalol or Phentolamine, while severe tachycardia may require Metoprolol or Atenolol. These interventions necessitate continuous monitoring of vital signs in a clinical setting. For children experiencing hypertension during overdose, specific counter-agent dosages are documented in the labeling.

Therapeutic Uses of Thomasin

The primary therapeutic role of Thomasin (Etilefrine) is the management of symptomatic low blood pressure, applying to conditions marked by a lack of circulatory stability. The medication is relevant for easing symptoms associated with poor circulation and is generally used for managing symptomatic hypotension, including cases of essential low blood pressure, orthostatic hypotension, and acute circulatory instability, such as that arising during procedures involving regional anesthesia.

Symptomatic Relief for Orthostatic Intolerance

This domain covers the primary use of Thomasin in helping to manage symptoms that interfere with daily functioning, specifically those related to positional changes. When symptoms like dizziness, lightheadedness, and the feeling of nearly fainting (presyncope) occur upon standing, the medication provides supportive relief that may assist with maintaining functional stability.

Support for Acute and Chronic Low Blood Pressure

Thomasin is applied in contexts where additional support for systemic low blood pressure is needed, covering both chronic management and acute scenarios. It offers symptomatic relief by helping to manage pronounced low blood pressure, thereby contributing to easing the overall symptom load.

Quick Fact: Relief for Orthostatic Dizziness

Thomasin is commonly used to help address the disruptive cluster of symptoms that appear suddenly when a patient moves from a resting to an upright position. This supports patients during episodes of heightened discomfort by easing the overall symptom load.

Eligibility and Restrictions for Use

Eligibility for Thomasin (Etilefrine) According to Regulatory Labeling

The eligibility profile for Thomasin (Etilefrine) is strictly defined by government regulatory documents, outlining who is allowed to use the medicine and who is absolutely prohibited. The medication is primarily intended for adults managing symptomatic low blood pressure, including orthostatic hypotension.


Absolute Contraindications

Use of Thomasin is strictly contraindicated in patients with a history of hypertension, thyrotoxicosis, phaeochromocytoma, and narrow angle glaucoma. It is also prohibited for patients with certain severe pre-existing cardiovascular diseases, such as decompensated heart failure, and in cases where its use causes a paradoxical hypertensive reaction upon standing. For the tablet form, patients with specific hereditary sugar intolerances are ineligible. The medicine is also contraindicated during the first trimester of pregnancy.


Conditional Use and Restrictions

Use is restricted during the second and third trimesters of pregnancy, permitted only after a formal risk assessment. The label mandates special caution for patients with conditions like diabetes mellitus, hyperthyroidism, tachycardia, or cardiac arrhythmias. Use is generally not recommended for breastfeeding mothers due to insufficient data regarding its presence in breast milk.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The interaction profile of Thomasin is primarily structured around its metabolism and its pharmacologic effect on coagulation. Certain combinations are classified as contraindicated, while others require close patient monitoring.

Thomasin's most significant pharmacokinetic interactions are governed by the cytochrome P450 enzyme CYP2C9, which is essential for the clearance of its active S-enantiomer. Strong CYP2C9 inhibitors must be avoided as they substantially increase Thomasin's exposure, raising the risk of adverse events. Additionally, specific CYP2C9 genetic variations (e.g., 2 and 3 alleles) reduce Thomasin's clearance, which necessitates personalized management when interacting drugs are introduced.

Documented Interaction Categories

Interaction Type Practical Implication
Pharmacodynamic Increased bleeding risk with co-administered antiplatelet agents or other anticoagulants due to additive effects on the clotting cascade.
Antagonism Effectiveness may be reduced by products containing Vitamin K, including certain foods and supplements.
Other Substances Alcohol can variably suppress or enhance the drug's anticoagulant effect, requiring cautious consumption.

These official findings mandate that all healthcare professionals thoroughly review concomitant medications and consider patient-specific factors before administering Thomasin.

Mechanism of Action

Direct Activation of Cardiovascular Adrenergic Receptors

Thomasin's core mechanism relies on Etilefrine, which acts as a direct sympathomimetic agonist. It binds to and activates two principal targets: the alpha-1 (alpha1) receptors on blood vessel walls and the beta-1 (beta1) receptors located in the heart muscle. This initiates the signaling sequences that modulate cardiovascular activity.


Coordinated Modulation of Systemic Vascular Resistance and Cardiac Output

Activation of the alpha1 receptors leads to the contraction of vascular smooth muscle (vasoconstriction), which increases the Systemic Vascular Resistance (SVR) and increases venous return. Simultaneously, beta1 activation enhances the force and rate of myocardial contraction (cardiac output). This coordinated mechanistic cascade results in the elevation of Mean Arterial Pressure by influencing both the 'container' and the 'pump' of the circulatory system.


Inherent Mechanistic Constraints

The drug’s mechanism is subject to constraints, including the potential for receptor desensitization (tachyphylaxis) under continuous stimulation, which may cause the magnitude of receptor activation to decrease over time. Additionally, the mechanism can be functionally overridden if competing adrenergic antagonists block its target receptors.

Dosage and Administration Information

The medicine Thomasin, containing the active substance Etilefrine, is administered through both oral and parenteral routes to provide systemic support. The official administration guidelines define its use based on the required speed and duration of action.

Administration Routes and Forms

Thomasin is available for oral intake as standard 5 mg tablets and, in some regions, as extended-release capsules. For acute or severe circulatory support, the medicine is supplied as a parenteral solution for use via intravenous (IV) injection, intramuscular (IM), or subcutaneous (SC) routes. The dual forms allow for use in both chronic management and immediate, supervised clinical settings.

Standard Dosing and Frequency

The standard adult dose for the oral tablet is typically 5 mg to 10 mg per administration. This regimen is generally scheduled three times daily. Extended-release formulations, where available, require less frequent intake, typically once or twice daily. The total daily dose for the parenteral solution in adults is approximately 30 mg to 60 mg, often administered in divided doses or as a continuous infusion. Oral tablets may be swallowed with water with or without food.

Procedural Requirements

Official prescribing information details specific dose adjustments for pediatric patients, where the dosage is calculated based on age and body mass, requiring lower numeric doses than those for adults. The injectable solution requires administration by a qualified healthcare professional; if prepared for IV drip infusion, it must be diluted only with approved solutions such as physiological saline or 5% glucose. If a dose is missed and the next scheduled dose is imminent, the official instruction is to skip the missed dose and continue the regular schedule; a double dose must not be taken.

Recent Clinical Evidence

Thomasin: Recent Clinical Evidence


Evidence for Use in Chronic and Symptomatic Low Blood Pressure

Research has been evaluated in individuals with chronic low blood pressure, including orthostatic hypotension and recurrent fainting (vasovagal syncope). Studies, including older controlled trials and some randomized controlled trials (RCTs), monitored changes in physiological parameters like blood pressure and heart rate during positional changes. Findings related to patient-reported discomfort have been described. However, in long-term RCTs used in research exploring how symptoms change over time for conditions like vasovagal syncope, the medicine and placebo showed mixed findings regarding the prevention of spontaneous fainting recurrence over a one-year follow-up period.

Evidence for Use in Acute Circulatory Instability

The injectable form of Thomasin has been studied for managing acute drops in blood pressure associated with regional anesthesia during surgery. Randomized, double-blind trials examined maternal outcomes (incidence and duration of low blood pressure) and fetal outcomes (Apgar scores and umbilical cord pH). Comparative trials reported that the medicine helped maintain blood pressure, and fetal markers were observed in some studies to be comparable to other vasopressor agents. Research describes that variations in administration methods or alternative vasopressors may be associated with differences in the measured outcome.

Gaps in Research and Areas of Uncertainty

Follow-up durations in rigorous trials were generally limited to short-term physiological responses or approximately one year. Consequently, long-term effects are not fully established, and data for sustained continuous use are insufficient. Research quality varies across studies, and comparative evidence against all contemporary treatments is lacking. The results apply only to the populations studied, and certainty remains low regarding how symptoms evolved in the observed populations over extended periods of use.

Frequently Asked Questions (FAQ)

Common questions about Thomasin (FAQ)

Q: How quickly does Thomasin usually start working after the first use?

Official information indicates that Thomasin's onset of action depends on how it is administered. The solution given by injection (parenteral) works very quickly because it enters the bloodstream directly. In contrast, the oral tablet or capsule forms are absorbed through the digestive system, which results in a more gradual or delayed start of effect.

Q: Can Thomasin be taken with commonly used pain relievers?

Regulatory information does not specifically list interactions with every common pain reliever, such as those sold over the counter. The guidance provided focuses on medications that affect blood pressure or blood clotting. Therefore, it is described that any use of Thomasin alongside other routine medicines requires review and monitoring by a healthcare professional.

Q: Does Thomasin interact with herbal supplements like St. John's Wort?

Official warnings exist concerning the potential for certain substances to affect how Thomasin is processed in the body by influencing the CYP2C9 enzyme pathway. Those that induce or inhibit this pathway could potentially reduce Thomasin's effectiveness or increase the risk of adverse events. Official guidance emphasizes the need for a healthcare professional to review all supplements a patient is taking.

Q: Is Thomasin taken every day or only when needed?

The frequency of Thomasin use depends on the formulation prescribed. For chronic conditions, official documentation states that the oral tablets are typically taken on a fixed schedule, such as three times daily. The injectable solution, however, is generally reserved for acute needs and is administered only in a supervised clinical setting.

Q: Can Thomasin be used by people with a history of kidney issues?

Regulatory guidelines address the use of Thomasin in individuals with kidney problems, also known as renal impairment. Official information describes that caution is recommended, particularly for those with severe impairment. The need for a dose adjustment is also mentioned due to how kidney function can affect the drug's removal from the body.

Q: Does Thomasin interact with alcohol?

Official prescribing information states that consuming alcohol may vary the body’s response to Thomasin in a variable manner. Due to this unpredictable potential to either enhance or suppress the drug's effects, regulatory guidance describes that consumption of alcohol should be approached with extreme caution.

Q: Can Thomasin cause changes in sleep patterns?

According to official adverse reaction lists, Thomasin may cause changes related to sleep, specifically listing insomnia (difficulty sleeping) and restlessness. These effects are classified as uncommon, meaning they are reported in at least 1 in 1,000 but less than 1 in 100 people. Other changes to sleep, such as excessive sleepiness, are not explicitly noted in the official documentation.

Q: How does Thomasin affect someone's daily activities, like driving?

Official warnings state that Thomasin may cause side effects such as dizziness, palpitations, or tremor, which could potentially impair an individual’s ability to drive or operate machinery. These neurological and cardiovascular effects are classified as uncommon. The potential impact of these factors on daily activities is an important consideration.

Q: Is it normal to feel a bit nauseous when first starting Thomasin?

Nausea is listed in the official documents as an uncommon adverse reaction associated with Thomasin, meaning it is a known possible side effect of the medicine. However, the regulatory information does not specify whether this feeling of nausea is typically more pronounced or limited only to the first few days of starting treatment.

Q: Can Thomasin affect mood or cause emotional changes?

Official adverse reaction lists include anxiety and restlessness, which are documented effects related to the central nervous system. These reactions are considered uncommon, occurring in less than 1 in 100 people. The official labeling confirms that Thomasin can affect certain emotional states.

Q: Is Thomasin approved for use in children or adolescents?

Use of Thomasin in children and adolescents, known as pediatric patients, is addressed in official prescribing information. Regulatory documents include specific dosing instructions tailored to this population, which vary based on age and body weight. The inclusion of pediatric dosing indicates that the use of Thomasin in children is regulated.

Q: Do other medicines make Thomasin less effective?

Official documents indicate that Thomasin's effectiveness can be reduced by certain other medications. Specifically, this can occur if a drug blocks the same receptors Thomasin targets (adrenergic antagonists) or if another drug is an "enzyme inducer," which speeds up the body's clearance of Thomasin.

Q: Is there a risk of allergy with Thomasin?

The potential for an allergic reaction is addressed in the safety profile of Thomasin. Official documents recognize the risk of hypersensitivity reactions, which include allergy-like symptoms, as an adverse event. The frequency of these reactions is classified as "Not Known," meaning it cannot be reliably estimated from available data.

Q: How long does Thomasin stays in the body after the last dose?

Official information about the drug's action in the body (pharmacokinetics) includes data on its elimination half-life. The half-life describes the time it takes for the concentration of Thomasin in the bloodstream to be reduced by half. This information is used by healthcare professionals to estimate the timeline for when the medicine is substantially eliminated from the body.

Q: Is Thomasin considered a high-alert medication?

While 'high-alert' status is often determined by institutional safety organizations, the active substance in Thomasin is an adrenergic agonist with vasopressor action. Because medications that rapidly change blood pressure carry a high risk for serious patient harm if errors occur, this type of medicine is frequently designated as 'high-alert' in certain clinical settings.

Q: What is the difference between the brand name Thomasin and its chemical name?

Thomasin is the registered brand name under which the medicine is marketed. Official regulatory documents specify that the active chemical substance contained within the medicine is Etilefrine (sometimes referred to as Etilefrine Hydrochloride). The brand name is proprietary, while the chemical name is the official scientific designation.

Q: Are there any long-term health concerns associated with using Thomasin?

The official regulatory summary of clinical research addresses the long-term use of Thomasin. It is described that the duration of rigorous trials has been limited, and therefore, data regarding the full effects of the medicine during sustained, continuous use are considered insufficient. This means that long-term health concerns have not been definitively established or fully ruled out.

Q: Can Thomasin affect blood pressure?

Yes, Thomasin is designed to act on the cardiovascular system and its core purpose is to elevate blood pressure. However, the official safety profile also lists a marked increase in blood pressure as a possible adverse reaction of unknown frequency. This risk is also why uncontrolled high blood pressure is listed as a contraindication for using the medicine.

Q: What is the storage requirement for Thomasin tablets or capsules?

Official product information provides specific storage conditions for Thomasin tablets or capsules to ensure the medicine remains stable. These requirements typically specify a safe temperature range, such as room temperature, and advise that the medicine should be protected from excessive heat, light, and moisture.

Q: Is Thomasin available as a generic version?

Official records in various regulatory markets confirm that the active substance in Thomasin, which is Etilefrine, is available in generic versions. However, the commercial availability and the specific generic brands may vary depending on the country or region.

Q: Does the time of day matter when taking Thomasin?

The oral form of Thomasin is officially prescribed to be taken at a fixed frequency, such as three times daily, to maintain consistent drug levels throughout the day. While regulatory documents do not specify exact clock times for every dose, the prescribed schedule is intended to ensure consistent drug exposure.

How should Thomasin be stored and disposed of?

How to Store and Dispose of Thomasin (Etilefrine)

Storage and disposal requirements for Thomasin are strictly defined in regulatory documents to ensure product stability and environmental safety.

Official Storage Requirements

Storage Component Regulatory Mandate
Environmental Protection Must be stored light-resistant and the container kept tightly closed to protect it from moisture. Storage should be away from heat to prevent degradation.
Packaging Must be stored in its original, tight container. Unused portions of some specific liquid formulations must be discarded immediately and not stored.
Child Safety The medicine must be stored locked up and kept out of the reach of children.

Official Disposal Rules

Disposal must follow specific regulatory waste guidelines. The product must be taken to a hazardous or special waste collection point in accordance with local regulations. It is strictly mandated to avoid release to the environment, meaning Thomasin must not be discarded into wastewater, drains, or household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Thomasin found in:

A-Z Index: